Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Dale, G.L.; Beutler, E.
    Enzyme replacement therapy in Gaucher s disease: a rapid, high-yield method for purification of glucocerebrosidase (1976), Proc. Natl. Acad. Sci. USA, 73, 4672-4674.
    View publication on PubMedView publication on EuropePMC

Application

EC Number Application Comment Organism
3.2.1.45 medicine Gaucher disease, sphingolipoidose Homo sapiens

Natural Substrates/ Products (Substrates)

EC Number Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
3.2.1.45 glucocerebroside + H2O Homo sapiens
-
glucose + ceramide
-
?

Organism

EC Number Organism UniProt Comment Textmining
3.2.1.45 Homo sapiens
-
-
-

Purification (Commentary)

EC Number Purification (Comment) Organism
3.2.1.45
-
Homo sapiens

Source Tissue

EC Number Source Tissue Comment Organism Textmining
3.2.1.45 placenta
-
Homo sapiens
-

Specific Activity [micromol/min/mg]

EC Number Specific Activity Minimum [µmol/min/mg] Specific Activity Maximum [µmol/min/mg] Comment Organism
3.2.1.45 2.5
-
-
Homo sapiens

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
3.2.1.45 4-methylumbelliferyl-beta-D-glucopyranoside + H2O
-
Homo sapiens methylumbelliferone + glucose
-
?
3.2.1.45 glucocerebroside + H2O
-
Homo sapiens glucose + ceramide
-
?